Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Stage IV Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

被引：4

作者：

Besse, Benjamin ^{[1
]}

Garrido, Pilar ^{[2
]}

Puente, Javier ^{[3
]}

Cortot, Alexis ^{[4
]}

Eugenia Olmedo, Maria ^{[2
]}

Perol, Maurice ^{[5
]}

Gil, Maciej ^{[6
]}

Chao, Grace ^{[7
]}

Shahidi, Javad ^{[8
]}

Bennouna, Jaafar ^{[9
]}

机构：

[1] Gustave Roussy, Dept Canc Med, Villejuif, France

[2] Hosp Univ Ramon Y Cajal, Med Oncol Dept, Madrid, Spain

[3] Hosp Clin San Carlos, Med Oncol Dept, Madrid, Spain

[4] Lille Univ Hosp, Thorac Oncol, Lille, France

[5] Ctr Leon Berard, Grp Thorac & Orl, Lyon, France

[6] Eli Lilly, Warsaw, Poland

[7] Eli Lilly & Co, Bridgewater, MA USA

[8] Eli Lilly & Co Bridgewater, Bridgewater, MA USA

[9] Inst Cancerol LOuest, Nantes, France

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

non-small cell lung cancer; Necitumumab; pembrolizumab;

D O I：

10.1016/j.jtho.2016.11.451

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA09.11

引用

页码：S397 / S397

页数：1

共 50 条

[21] Proton therapy for stage I non-small cell lung cancer (NSCLC)
Nihei, K
Ogino, T
Ishikura, S
Nishimura, H
Kawashima, M
Arahira, S
Onozawa, M
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S282 - S282
[22] Pembrolizumab-Induced Bronchiolitis in a Patient with Stage IV Non-Small Cell Lung Cancer
Blanchard, A.
Bouchard, N.
Larivee, P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[23] EVALUATION OF THE EFFICACY AND SAFETY OF BEVACIZUMAB IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
Okada, Asuka
Fukuoka, Kazuya
Okuwa, Hisaya
Kamiya, Hitomi
Honda, Miki
Masachika, Eriko
Otsuki, Taiichiro
Maeda, Risa
Hirayama, Noriko
Terada, Takayuki
Murakami, Aki
Yamada, Syusai
Tamura, Kuninobu
Tabata, Chiharu
Nakano, Takashi
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1202 - S1203
[24] Non-small cell lung cancer therapy: safety and efficacy in the elderly
Glotzer, Owen S.
Fabian, Thomas
Chandra, Anurag
Bakhos, Charles T.
DRUG HEALTHCARE AND PATIENT SAFETY, 2013, 5 : 113 - 121
[25] Efficacy and Safety of Anlotinib in Combination with Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Han, B.
Chu, T.
Zhang, X.
Zhong, H.
Zhang, B.
Wang, H.
Gu, A.
Zhang, W.
Shi, C.
Zhong, R.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S398 - S398
[26] Efficacy and safety of necitumumab (neci) in East Asian (EA) patients (pts) with stage IV squamous non-small-cell lung cancer (NSCLC): a subanalysis of the SQUIRE trial
Park, K.
Cho, E. K.
Bello, M.
Ahn, M. -J.
Thongprasert, S.
Song, E. -K.
Soldatenkova, V.
Depenbrock, H.
Puri, T.
Orlando, M.
ANNALS OF ONCOLOGY, 2015, 26 : 132 - 132
[27] Non-small Cell Lung Cancer (NSCLC) Necitumumab in advanced squamous NSCLC approved with EGFR-Expression
Sankawa, Yuri
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (06) : 395 - 396
[28] Necitumumab for the treatment of stage IV metastatic squamous non-small-cell lung cancer
Sacco, Paola Claudia
Maione, Paolo
Rossi, Antonio
Sgambato, Assunta
Casaluce, Francesca
Palazzolo, Giovanni
Gridelli, Cesare
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (03) : 245 - 254
[29] Molecular testing prior to first-line therapy in patients with stage IV nonsquamous non-small cell lung cancer (NSCLC): A survey of US medical oncologists
Green, Mark R.
Willey, Joanne
Buettner, Arden
Lankford, Maria
Neely, Doug B.
Ramalingam, Suresh S.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[30] Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
Cohen, Martin H.
Cortazar, Patricia
Justice, Robert
Pazdur, Richard
ONCOLOGIST, 2010, 15 (12): : 1352 - 1358

← 1 2 3 4 5 →